Roswell Park Comprehensive Cancer Center

Elisa M. Rodriguez, PhD, MS, has been appointed chief diversity and equity officer for faculty at Roswell Park Comprehensive Cancer Center.

Pawel Kalinski, MD, PhD, has been promoted to Jacobs family endowed chair of immunology at Roswell Park Comprehensive Cancer Center.

Agnes Witkiewicz, MD, has been appointed director of cancer genetics and genomics at Roswell Park Comprehensive Cancer Center.

Renuka Iyer, MD, received the Mark R. Clements Award for Vision, Innovation and Collaboration from the Cholangiocarcinoma Foundation.

Gyorgy Paragh, MD, PhD, has been appointed Lawrence P. & Joan Castellani family chair in dermatology at Roswell Park Comprehensive Cancer Center.

Use of a modified herpesvirus with and without radiation showed promising efficacy and safety for the treatment of children with recurrent or progressive high-grade glioma, according to results of a phase 1 trial.

Approximately 16% of children with sporadic neuroblastoma harbored rare pathogenic or likely pathogenic variants in a cancer predisposition gene, most of which were inherited, according to study results.

Patients with head and neck cancer who reported high financial toxicity at baseline appeared nearly twice as likely to experience poor outcomes, according to study results published in Oral Oncology.

The majority of patients with chronic graft-versus-host disease are unable to discontinue immunosuppressive therapy for more than 1 year, according to retrospective study results presented at TCT Meetings Digital Experience.

Roswell Park Comprehensive Cancer Center has promoted four physicians to leadership roles in its clinical research program.